GRAIL Inc. ( GRAL) - Stock Earnings
GRAL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
GRAL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -89.0 million USD | 36.2 million USD |
| 2025Q4 | -99.2 million USD | 43.6 million USD |
| 2026Q1 | -93.2 million USD | 40.8 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GRAL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.5 billion USD | 93.1 million USD |
| 2024 | -2.0 billion USD | 125.6 million USD |
| 2025 | -408.4 million USD | 147.2 million USD |
| 2026 Est. | — | — |
GRAL
Price: $72.71
52 week price:
Earnings Per Share: -10.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 3.0 billion